Hicin Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 32.6785 million yuan, a year-on-year increase of 16.22%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Hicin Pharmaceutical released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 472 million yuan, a year-on-year increase of 30.80%. The net profit attributable to shareholders of the listed company was 32.6785 million yuan, a year-on-year increase of 16.22%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 29.5431 million yuan, a year-on-year increase of 1.64%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments